acetylshikonin has been researched along with Fatty Liver, Nonalcoholic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Su, M; Zeng, J; Zhu, B | 1 |
He, Y; Li, QS; Su, ML; Zhu, BH | 1 |
2 other study(ies) available for acetylshikonin and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Autophagy is involved in acetylshikonin ameliorating non-alcoholic steatohepatitis through AMPK/mTOR pathway.
Topics: AMP-Activated Protein Kinases; Animals; Anthraquinones; Autophagy; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; TOR Serine-Threonine Kinases | 2018 |
Efficacy of Acetylshikonin in Preventing Obesity and Hepatic Steatosis in db/db Mice.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Aspartate Aminotransferases; Body Weight; Cytokines; Disease Models, Animal; Eating; Fatty Acids, Nonesterified; Lipid Metabolism; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Triglycerides | 2016 |